HIV Pre-Immunization and Immunotherapy
Country:
US
Docket No:
436313-000200
Publication Number:
2018-0177866
Patent Expiry:
07/08/2036
Claims Scope:
Allowed. Issue fee due March 26, 2024.
Sequence Agnostic
Methods of treating HIV in a subject via
- Immunizing the subject with an HIV vaccine,
- purifying PBMCs obtained from the subject,
- contacting the PBMCs with an HIV vaccine,
- transducing the PBMCs with a vector encoding,
- CCR5 and Tat, or
- Vif and Tat, or
- CCR5, Vif and Tat,
followed by a culturing step and infusion step.